PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism

Cinacalcet lowers parathyroid hormone levels. Whether it can prolong survival of people with chronic kidney disease (CKD) complicated by secondary hyperparathyroidism (SHPT) remains controversial, in part because a recent randomized trial excluded patients with iPTH <300 pg/ml. We examined cinaca...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Akizawa, Tadao, Kurita, Noriaki, Mizobuchi, Masahide, Fukagawa, Masafumi, Onishi, Yoshihiro, Yamaguchi, Takuhiro, Ellis, Alan R., Fukuma, Shingo, Alan Brookhart, M., Hasegawa, Takeshi, Kurokawa, Kiyoshi, Fukuhara, Shunichi
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829837/
https://ncbi.nlm.nih.gov/pubmed/27071541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep19612
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars